White Paper: Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry


Research Info
ID: GBC-WP03
Price: $0
Pages/Slides: 7
Delivery Format:
PDF


Please click on "Add to Cart" to obtain the free study findings for "Assurance and Risk-Based Approach for the Biopharmaceutical Industry."
If you would like to purchase the full study this summary is based on click here.


Industries Profiled:
Pharmaceutical; Health Care

Companies Profiled:
Abbott Laboratories; Wyeth; Boehringer-Ingelheim; Johnson & Johnson; Novartis; Eli Lilly and Company


All contents copyright 1999-2012 Best Practices, LLC (919) 403-0251
Site Map | Read our Privacy Policy.